SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-335910
Filing Date
2017-11-07
Accepted
2017-11-07 17:14:45
Documents
54
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d395476d10q.htm 10-Q 653737
2 EX-31.1 d395476dex311.htm EX-31.1 6201
3 EX-31.2 d395476dex312.htm EX-31.2 6205
4 EX-32.1 d395476dex321.htm EX-32.1 5942
  Complete submission text file 0001193125-17-335910.txt   2658550

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT zfgn-20170930.xml EX-101.INS 420627
6 XBRL TAXONOMY EXTENSION SCHEMA zfgn-20170930.xsd EX-101.SCH 32153
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zfgn-20170930_cal.xml EX-101.CAL 48612
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zfgn-20170930_def.xml EX-101.DEF 85428
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE zfgn-20170930_lab.xml EX-101.LAB 249369
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zfgn-20170930_pre.xml EX-101.PRE 167882
Mailing Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114
Business Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114 617-622-4003
ZAFGEN, INC. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36510 | Film No.: 171184368
SIC: 2834 Pharmaceutical Preparations